<DOC>
	<DOCNO>NCT00853593</DOCNO>
	<brief_summary>This study design show new lead , pace leave bottom chamber ( left ventricle ) heart , safe effective . Using lead left side heart show potentially improve heart failure symptom . The shape size new lead may make good choice patient physician .</brief_summary>
	<brief_title>Model 4396 Left Ventricular ( LV ) Lead Study</brief_title>
	<detailed_description>This study prospective , multi-center , non-randomized design . All consent patient meet inclusion exclusion criterion may receive investigational lead . The study design statistical power show safety one-month implant . It also statistical power show effectiveness one-month three-months implant .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>CRT/Cardiac Resynchronization TherapyDefibrillator ( CRTD ) indication , New York Heart Association ( NYHA ) III IV , indicate implantable cardiac defibrillator ( ICD ) CRTD implant , patient consent , geographically stable LV lead implant attempt last 30 day , unstable angina acute myocardial infarction ( MI ) past 30 day , coronary artery bypass graft ( CABG ) percutaneous transluminal coronary angioplasty ( PTCA ) past 3 month , contraindicate transvenous pacing , heart transplant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>heart failure</keyword>
	<keyword>cardiac pacing</keyword>
	<keyword>cardiac resynchronization therapy</keyword>
	<keyword>leave ventricular lead</keyword>
</DOC>